Studies by Vertex Pharmaceuticals then identified VRT-422 and VRT-325, which restored F508del CFTR-mediated chloride current to ~10% of wild-type CFTR current in human bronchial epithelial (HBE) cells, a level associated with a mild CF phenotype [176]. Here, CFTR is linked to cystic fibrosis.